Literature DB >> 8705683

Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies.

D Harning1, J Spenter, A Metsis, J Vuust, E Petersen.   

Abstract

The immunodominant surface antigen of Toxoplasma gondii, surface antigen 1 (SAG1), was expressed in Escherichia coli as a fusion protein containing a majority of the SAG1 protein supplied with six histidyl residues in the N-terminal end. The recombinant protein was purified on a Ni-chelate column and then on a fast-performance liquid chromatography column and was in a nonreduced condition. It was recognized by T. gondii-specific human immunoglobulin G (IgG) and IgM antibodies as well as by a mouse monoclonal antibody (S13) recognizing only nonreduced native SAG1. Antibodies induced in mice by the recombinant SAG1 recognized native SAG1 from the T. gondii RH isolate in culture. Recombinant SAG1 is suitable for use in diagnostic systems for detecting anti-SAG1-specific IgG and IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705683      PMCID: PMC170346          DOI: 10.1128/cdli.3.3.355-357.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Phosphorylation of Toxoplasma gondii major surface antigens.

Authors:  S Tomavo; A Martinage; J F Dubremetz
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  Cloning, sequencing, expression, and functional studies of a 15,000-molecular-weight Haemophilus somnus antigen similar to Escherichia coli ribosomal protein S9.

Authors:  M Theisen; A A Potter
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

3.  Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii.

Authors:  J L Burg; D Perelman; L H Kasper; P L Ware; J C Boothroyd
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

4.  Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.

Authors:  C Rodriguez; D Afchain; A Capron; C Dissous; F Santoro
Journal:  Eur J Immunol       Date:  1985-07       Impact factor: 5.532

5.  Expression of Toxoplasma gondii P30 as fusions with glutathione S-transferase in animal cells by Sindbis recombinant virus.

Authors:  C Xiong; R B Grieve; K Kim; J C Boothroyd
Journal:  Mol Biochem Parasitol       Date:  1993-09       Impact factor: 1.759

6.  Toxoplasma gondii: characterization of a monoclonal antibody recognizing antigens of 36 and 38 kDa with acid phosphatase activity located in dense granules and rhoptries.

Authors:  A Metsis; E Pettsersen; E Petersen
Journal:  Exp Parasitol       Date:  1995-12       Impact factor: 2.011

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain.

Authors:  M W Van Dyke; M Sirito; M Sawadogo
Journal:  Gene       Date:  1992-02-01       Impact factor: 3.688

9.  The major surface antigen, P30, of Toxoplasma gondii is anchored by a glycolipid.

Authors:  S D Nagel; J C Boothroyd
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

10.  New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues.

Authors:  E Hochuli; H Döbeli; A Schacher
Journal:  J Chromatogr       Date:  1987-12-18
View more
  28 in total

Review 1.  Review on the identification and role of Toxoplasma gondii antigenic epitopes.

Authors:  Yanhua Wang; Guangxiang Wang; Jianping Cai; Hong Yin
Journal:  Parasitol Res       Date:  2015-11-19       Impact factor: 2.289

2.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host.

Authors:  David J P Ferguson; Fiona L Henriquez; Michael J Kirisits; Stephen P Muench; Sean T Prigge; David W Rice; Craig W Roberts; Rima L McLeod
Journal:  Eukaryot Cell       Date:  2005-04

4.  Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.

Authors:  Yan-Lin Tao; Xun-Jia Cheng; Yong-Feng Fu; Hideo Tsukamoto; Eisaku Yoshihara; Hiroshi Tachibana
Journal:  Parasitol Res       Date:  2008-04-30       Impact factor: 2.289

5.  Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.

Authors:  V Letscher-Bru; O Villard; B Risse; M Zauke; J P Klein; T T Kien
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

7.  A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis.

Authors:  Lucyna Holec-Gąsior; Bartłomiej Ferra; Dorota Drapała; Dariusz Lautenbach; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

8.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice.

Authors:  Melina Laguía-Becher; Valentina Martín; Mauricio Kraemer; Mariana Corigliano; María L Yacono; Alejandra Goldman; Marina Clemente
Journal:  BMC Biotechnol       Date:  2010-07-15       Impact factor: 2.563

10.  Identification and characterization of Toxoplasma SIP, a conserved apicomplexan cytoskeleton protein involved in maintaining the shape, motility and virulence of the parasite.

Authors:  Gaelle Lentini; Marie Kong-Hap; Hiba El Hajj; Maria Francia; Cyrille Claudet; Boris Striepen; Jean-François Dubremetz; Maryse Lebrun
Journal:  Cell Microbiol       Date:  2014-08-30       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.